GlassScriptPhysician profile
Rehan Mahmud
NPI 1306826458
$2,133.40
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $71.36 · 2021: $28.53 · 2023: $1,758 · 2024: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,505 · Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,504.74 |
| Food and Beverage | $422.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,709.82 | 2021-2024 | Azure Xt Dr Mri Surescan, Selectsecure, Linq II |
| Lemaitre Vascular, INC. | $213.49 | 2023-2024 | Tyke, Patch, Pledget and Intracardiac, Xenosure Biologic Patch |
| Amgen INC. | $86.37 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.96 | 2019-2020 | |
| Biotronik INC. | $20.02 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.62 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.60 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rehan Mahmud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.